Saliva‐based testing for diagnosis of SARS‐CoV‐2 infection: A meta‐analysis

Diagnostic testing of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is primarily conducted from an upper respiratory specimen, like nasopharyngeal swab (NPS) or oropharyngeal swab (OPS) obtained by the health‐care personnel.

Saved in:
Bibliographic Details
Published in:Journal of Medical Virology 2021-03, Vol.93 (3), p.1256-1258
Main Authors: Kivelä, Jesper M., Jarva, Hanna, Lappalainen, Maija, Kurkela, Satu
Format: Article
Language:English
Subjects:
Adult
COVID-19 - diagnosis
COVID-19 Testing - methods
Humans
Molecular Diagnostic Techniques
Saliva
Saliva - virology
SARS-CoV-2 - isolation & purification
Sensitivity and Specificity
Severe acute respiratory syndrome coronavirus 2
Specimen Handling
Virology
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Diagnostic testing of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is primarily conducted from an upper respiratory specimen, like nasopharyngeal swab (NPS) or oropharyngeal swab (OPS) obtained by the health‐care personnel.
ISSN:0146-6615
1096-9071
DOI:10.1002/jmv.26613